INDIGO recently expanded its portfolio of assays for cancer research with the addition of a new assay for Human Tumor Protein P53. The new assay is available in an all-inclusive kit that allows researchers to screen small numbers of test compounds or as custom bulk reagents for high throughput screening applications. INDIGO can also perform the assay in its own lab as a service for researchers.
Read More
Our Cell-based Reporter Assays are all-inclusive assay systems that feature engineered receptor-specific reporter cells prepared using our unique CryoMite™ process. INDIGO’s assay kits are engineered to provide optimal assay sensitivity and dynamic range when quantifying receptor activity. Assays are available as all-inclusive kits and as contract screening services. Get the data you need from the company with the world’s largest portfolio of nuclear receptor reporter assays.
Explore Assays
INDIGO’s effects-based bioassay solutions compliment traditional analytical chemistry approaches for the examination of water quality and can help protect human and environmental health.
Learn More
Request a quote for nuclear receptor assay panels, kits or services, or in vitro toxicology solutions
Request Quote
Scientific studies, scholarly articles, and patent information on Nuclear Receptors and Nuclear Receptor research.
Publications